| Product Code: ETC10792171 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Pharma Ophthalmic Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Pharma Ophthalmic Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Pharma Ophthalmic Market - Industry Life Cycle |
3.4 Sweden Pharma Ophthalmic Market - Porter's Five Forces |
3.5 Sweden Pharma Ophthalmic Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Sweden Pharma Ophthalmic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Pharma Ophthalmic Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.8 Sweden Pharma Ophthalmic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Sweden Pharma Ophthalmic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Pharma Ophthalmic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye disorders and diseases in Sweden |
4.2.2 Technological advancements in ophthalmic pharmaceuticals |
4.2.3 Growing geriatric population leading to higher demand for ophthalmic medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of ophthalmic drugs |
4.3.2 High competition among pharmaceutical companies in the Swedish market |
4.3.3 Pricing pressures and reimbursement challenges for ophthalmic medications |
5 Sweden Pharma Ophthalmic Market Trends |
6 Sweden Pharma Ophthalmic Market, By Types |
6.1 Sweden Pharma Ophthalmic Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Pharma Ophthalmic Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Sweden Pharma Ophthalmic Market Revenues & Volume, By Prescription Eye Drops, 2021 - 2031F |
6.1.4 Sweden Pharma Ophthalmic Market Revenues & Volume, By OTC Eye Drops, 2021 - 2031F |
6.1.5 Sweden Pharma Ophthalmic Market Revenues & Volume, By Ophthalmic Ointments, 2021 - 2031F |
6.1.6 Sweden Pharma Ophthalmic Market Revenues & Volume, By Surgical Ophthalmic Drugs, 2021 - 2031F |
6.1.7 Sweden Pharma Ophthalmic Market Revenues & Volume, By Contact Lens Solutions, 2021 - 2031F |
6.2 Sweden Pharma Ophthalmic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Pharma Ophthalmic Market Revenues & Volume, By Glaucoma, 2021 - 2031F |
6.2.3 Sweden Pharma Ophthalmic Market Revenues & Volume, By Dry Eye Syndrome, 2021 - 2031F |
6.2.4 Sweden Pharma Ophthalmic Market Revenues & Volume, By Conjunctivitis, 2021 - 2031F |
6.2.5 Sweden Pharma Ophthalmic Market Revenues & Volume, By Cataract Surgery, 2021 - 2031F |
6.2.6 Sweden Pharma Ophthalmic Market Revenues & Volume, By Contact Lens Hygiene, 2021 - 2031F |
6.3 Sweden Pharma Ophthalmic Market, By Form |
6.3.1 Overview and Analysis |
6.3.2 Sweden Pharma Ophthalmic Market Revenues & Volume, By Solution, 2021 - 2031F |
6.3.3 Sweden Pharma Ophthalmic Market Revenues & Volume, By Suspension, 2021 - 2031F |
6.3.4 Sweden Pharma Ophthalmic Market Revenues & Volume, By Gel, 2021 - 2031F |
6.3.5 Sweden Pharma Ophthalmic Market Revenues & Volume, By Emulsion, 2021 - 2031F |
6.3.6 Sweden Pharma Ophthalmic Market Revenues & Volume, By Liquid, 2021 - 2031F |
6.4 Sweden Pharma Ophthalmic Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Pharma Ophthalmic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Sweden Pharma Ophthalmic Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Sweden Pharma Ophthalmic Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Sweden Pharma Ophthalmic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.6 Sweden Pharma Ophthalmic Market Revenues & Volume, By Supermarkets, 2021 - 2031F |
6.5 Sweden Pharma Ophthalmic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Sweden Pharma Ophthalmic Market Revenues & Volume, By Patients, 2021 - 2031F |
6.5.3 Sweden Pharma Ophthalmic Market Revenues & Volume, By Consumers, 2021 - 2031F |
6.5.4 Sweden Pharma Ophthalmic Market Revenues & Volume, By Optometrists, 2021 - 2031F |
6.5.5 Sweden Pharma Ophthalmic Market Revenues & Volume, By Surgeons, 2021 - 2031F |
6.5.6 Sweden Pharma Ophthalmic Market Revenues & Volume, By Contact Lens Users, 2021 - 2031F |
7 Sweden Pharma Ophthalmic Market Import-Export Trade Statistics |
7.1 Sweden Pharma Ophthalmic Market Export to Major Countries |
7.2 Sweden Pharma Ophthalmic Market Imports from Major Countries |
8 Sweden Pharma Ophthalmic Market Key Performance Indicators |
8.1 Number of clinical trials for innovative ophthalmic drugs in Sweden |
8.2 Adoption rate of advanced ophthalmic treatments in healthcare facilities |
8.3 Percentage of ophthalmologists satisfied with the efficacy of available pharmaceutical products |
9 Sweden Pharma Ophthalmic Market - Opportunity Assessment |
9.1 Sweden Pharma Ophthalmic Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Sweden Pharma Ophthalmic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Pharma Ophthalmic Market Opportunity Assessment, By Form, 2021 & 2031F |
9.4 Sweden Pharma Ophthalmic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Sweden Pharma Ophthalmic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Pharma Ophthalmic Market - Competitive Landscape |
10.1 Sweden Pharma Ophthalmic Market Revenue Share, By Companies, 2024 |
10.2 Sweden Pharma Ophthalmic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here